Study explores the mediatory role of gut microbiota in metabolic syndrome and sleep disorders

Researchers described gut microbiota and metabolic alterations common to metabolic syndrome (MetS) and sleep disorders.

Cautious Optimism for Surgical LAA Closure for People Without Afib

Adding prophylactic left atrial appendage (LAA) closure to planned cardiac surgery was linked to lower stroke risk for patients without atrial fibrillation (Afib, or AF),

September 13, 2024

FDA rejects Amneal’s extended-release Parkinson’s treatment, seeking more safety data

The FDA has rejected specialty pharma and generics maker Amneal Pharmaceuticals’ extended-release capsule for Parkinson’s disease, which combines two drugs that have long been used

July 6, 2023

Exclusive: David Hough on Lykos’ Path to Resubmission – Psychedelic Alpha

Following Lykos Therapeutics’ receipt of a Complete Response Letter (CRL) from the FDA, which is effectively a rejection of its first shot at approval of MDMA-assisted therapy for PTSD,

September 4, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.